Log in
Enquire now
Dxcover

Dxcover

Multiomic spectral analysis (MOSA-Dx™) platform for early detection of solid tumour cancers.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
Mark Hegarty
0
CFO
‌
John Duncan
0
Company Operating Status
Active
COO
‌
David Eustace
0
Country
Scotland
Scotland
Email Address
info@dxcover.com
Facebook URL
@dxcoverltd
Founded Date
January 1, 2016
Founder
‌
Mark Hegarty
Full Address
Suite RC534, Royal College Building 204 George Street Glasgow G1 1XW
0
Headquarters
Glasgow
Glasgow
Industry
Technology
Technology
Diagnosis
Diagnosis
Cancer
Cancer
Biology
Biology
Oncology
Oncology
Health technology
Health technology
‌
Deep Tech
Biotechnology
Biotechnology
Internal medicine
Internal medicine
Healthcare
Healthcare
•••
Investors
Macmillan Cancer Support
Macmillan Cancer Support
University of Strathclyde
University of Strathclyde
‌
Eos
‌
SIS Ventures
British Business Bank PLC
British Business Bank PLC
‌
Norcliffe Capital
Latest Funding Round Date
February 3, 2025
Latest Funding Round Amount (USD)
6,200,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/dxcover-ltd
Location
Glasgow
Glasgow
0
United Kingdom
United Kingdom
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...226078-75
Previous Name
ClinSpec Diagnostics Limited
Total Funding Amount (USD)
21,900,000
Twitter URL
@dxcover
Official Website
dxcover.com

Find more companies like Dxcover

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.